Metabolic syndrome in type 2 diabetes: Comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans

Diabetology and Metabolic Syndrome

Volumn 4, Issue 1, 2012, Pages

  Kengne, Andre P ^a   Limen, Serge N ^b   Sobngwi, Eugene ^c,d   Djouogo, Cathérine F T ^b   Nouedoui, Christophe ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Higher Institute of Health Sciences   (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cameroon; Concordance; Diabetes mellitus; Metabolic syndrome; Prevalence; Sub Saharan Africa

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AFRICA; AGED; ARTICLE; BLOOD PRESSURE; CAMEROON; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

EID: 84861595832     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-4-22     Document Type: Article

References (37)

1. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. Zimmet P, McCarty DJ, de Courten MP, J Diabetes Complications 1997 11 60 68 10.1016/S1056-8727(96)00090-6 9101389 (Pubitemid 27163201)
2. BM, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G. Marchesini G, Melchionda N: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001 50 1844 1850
3. Role of insulin resistance in human disease. Reaven GM, Diabetes 1988 37 1595 1607 10.2337/diabetes.37.12.1595 3056758 (Pubitemid 19004941)
4. International Diabetes Federation, The IDF consensus worldwide definition of the metabolic syndrome 2005 Available at http://www.idf.org/webdata/docs/ Metabolic-syndrome-definition.pdf. Accessed on 28.02.2012
5. Metabolic Syndrome:A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation. Paresh D, Ahmad A, Ajay C, Priya M, Rajesh G, Circulation 2005 111 1448 1454 10.1161/01.CIR.0000158483.13093.9D 15781756 (Pubitemid 40396812)
6. The Metabolic Syndrome as Predictor of Type 2 Diabetes. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, Diabetes Care 2003 26 3153 3159 10.2337/diacare.26.11.3153 14578254 (Pubitemid 37339513)
7. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Alberti KG, Zimmet P, Diabet Med 1998 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693 (Pubitemid 28319935)
8. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Balkau B, Charles MA, Diabet Med 1999 16 442 443 10342346
9. Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the third national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Panel Treatment III). Expert Panel on Detection, Jama 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
10. International Diabetes Federation (ed.), Diabetes Atlas Brussels 5 2011
11. Metabolic syndrome in Africa: Current trends. Okafor CI, Indian J Endocrinol Metab 2012 16 56 66 10.4103/2230-8210.91191 22276253
12. The atherosclerosis epidemic: methodology, nosology, and clinical practice. Faergeman O, Am J Cardiol 2001 88 4E 7E 11473736 (Pubitemid 32721975)
13. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC, Atherosclerosis 2007 193 70 76 10.1016/j.atherosclerosis.2006.08.037 17011567 (Pubitemid 46776712)
14. Metabolic syndrome in subjects with type-2 diabetes mellitus. Alebiosu CO, Odusan BO, J Natl Med Assoc 2004 96 817 821 15233492 (Pubitemid 38745790)
15. Prevalence of the Metabolic Syndrome among Nigerians with Type 2 Diabetes. Adediran OS, Edo AE, Jimoh AK, Ohwovoriole AE, Diabetes Int 2007 15 13 14
16. Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. Isezuo SA, Ezunu E, J Natl Med Assoc 2005 97 557 563 15868776 (Pubitemid 40463586)
17. Is high density lipoprotein cholesterol useful in diagnosis of metabolic syndrome in native Africans with type 2 diabetes? Isezuo SA, Ethn Dis 2005 15 6 10 15720043 (Pubitemid 40310048)
18. Prevalence of the metabolic syndrome among patients with type 2 diabetes mellitus in urban North-central Nigeria. Puepet FH, Uloko A, Akogu IY, Aniekwensi E, Afr J Endocrinol Metab 2009 8 10 12
19. Prevalence of the metabolic syndrome among patients with type 2 diabetes mellitus in Uyo, Nigeria. Unadike BC, Akpan NA, Peters EJ, Essien IO, Essien OE, Afr J Endocrinol Metab 2009 8 7 9
20. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Onyekwere CA, Ogbera AO, Balogun BO, Ann Hepatol 2011 10 119 124 21502672
21. Hyperuricaemia and the metabolic syndrome in type 2 DM. Ogbera AO, Azenabor AO, Diabetol Metab Syndr 2010 2 24 10.1186/1758-5996-2-24 20406485
22. Menopausal symptoms and the metabolic syndrome in Nigerian women with type 2 diabetes mellitus. Ogbera A, Fasanmade O, Kalra S, Climacteric 2011 14 75 82 10.3109/13697130903568526 20148729
23. Prevalence and gender distribution of the metabolic syndrome. Ogbera AO, Diabetol Metab Syndr 2010 2 1 10.1186/1758-5996-2-1 20180954
24. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
25. Metabolic syndrome disorders in urban black Zimbabweans with type 2 Diabetes mellitus. Makuyana D, Gomo Z, Munyombwe T, Matenga JA, Hakim JG, Cent Afr J Med 2004 50 24 29 15490713
26. Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Kelliny C, William J, Riesen W, Paccaud F, Bovet P, Cardiovasc Diabetol 2008 7 27 10.1186/1475-2840-7-27 18801172
27. The metabolic syndrome, insulin resistance, and its surrogates in African and white subjects with type 2 diabetes in South Africa. Kalk WJ, Joffe BI, Metab Syndr Relat Disord 2008 6 247 255 10.1089/met.2008.0003 19067527
28. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients. Monami M, Marchionni N, Masotti G, Mannucci E, Diabetes Obes Metab 2007 9 350 353 10.1111/j.1463-1326.2006. 00615.x 17391162 (Pubitemid 46502054)
29. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease. Luk AO, Ma RC, So WY, Yang XL, Kong AP, Ozaki R, Ko GT, Chow CC, Cockram CS, Chan JC, et al. Diabet Med 2008 25 1419 1425 10.1111/j.1464-5491.2008.02602.x 19046240
30. Metabolic syndrome in type 2 diabetes mellitus in isfahan, iran: prevalence and risk factors. Janghorbani M, Amini M, Metab Syndr Relat Disord 2007 5 243 254 10.1089/met.2005.0010 18370778 (Pubitemid 47402030)
31. The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South african community. Motala AA, Esterhuizen T, Pirie FJ, Omar MA, Diabetes Care 2011 34 1032 1037 10.2337/dc10-1921 21330644
32. Cardiovascular Risk Reduction in Diabetes in Sub-Saharan-Africa: What should the Priorities be in the Absence of Global Risk Evaluation Tools? Kengne AP, Njamnshi AK, Mbanya JC, Clinical Medicine: Cardiology 2008 2 25 31
33. Admission trends over 8years for diabetic foot ulceration in a specialized diabetes unit in cameroon. Kengne AP, Djouogo CF, Dehayem MY, Fezeu L, Sobngwi E, Lekoubou A, Mbanya JC, Int J Low Extrem Wounds 2009 8 180 186 10.1177/1534734609349704 19934180
34. Sample size for the kappa-statistic of interrater agreement. Reichenheim ME, Stata Technical Bulletin 2000 58 41 45
35. Large sample standard errors for kappa and weighted kappa. Fleiss JL, Cohen J, Everitt BS, Psychol Bull 1969 72 323 327
36. Fleiss JL, Statistical Methods for Rates and Proportions Wiley & Sons, New York 2 1981
37. Sample size calculations for Cohensk. Cantor AB, Psychological Methods 1996 1 150 153